Bruno Bruins
Director/Board Member at Institute for Translational Vaccinology
Profile
Bruno Bruins is currently a Member-Supervisory Board at the Institute for Translational Vaccinology and at Intravacc BV.
He previously served as the Minister for Medical Care in the Government of the Netherlands.
Bruno Bruins active positions
Companies | Position | Start |
---|---|---|
Institute for Translational Vaccinology
Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Director/Board Member | 2020-12-31 |
Intravacc BV | Director/Board Member | 2020-12-31 |
Former positions of Bruno Bruins
Companies | Position | End |
---|---|---|
Government of the Netherlands | Minister of Government | 2020-03-18 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Government of the Netherlands | Government |
Institute for Translational Vaccinology
Institute for Translational Vaccinology BiotechnologyHealth Technology Institute for Translational Vaccinology is a Dutch independent company that partners with clients in vaccine development, from discovery to pilot production to clinical studies. The non-profit company is based in Bilthoven, Netherlands. Intravacc designs and creates the best candidate organisms for vaccine strain, looking for the highest immunity, potency, and production yield. The company substantially reduces the risks and costs involved with developing vaccines by bridging the gap between concept and late-stage clinical studies. Intravacc's upstream processing expertise covers both bacterial and cell cultivation as well as virus propagation in reactors ranging from 1l up to 200l. The company's scientists design, develop, and improve vaccine formulations that are suitable for the intended administration route and stable upon storage. | Health Technology |
Intravacc BV | Health Technology |
- Stock Market
- Insiders
- Bruno Bruins